<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Rausch, Paula</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Saver, Jeffrey L.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Paramedic Delivery of Magnesium Does Not Improve Outcomes in Patients with Acute Stroke</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-06-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">8-8</style></pages><abstract><style  face="normal" font="default" size="100%">Early intervention is critical in patients with acute stroke, and there is a narrow time frame in which to pursue acute therapies [Saver JL. Stroke 2006; Saver JL et al. JAMA 2013]. Approximately 35% to 70% of patients with stroke arrive by ambulance. This article presents results from the Field Administration of Stroke Therapy—Magnesium (FAST-MAG) trial, a prehospital, multicenter, randomized, placebo-controlled efficacy study whose aim was to test whether intravenous magnesium sulfate given within 2 hours of symptom onset improves the outcomes of patients with acute stroke.</style></abstract><number><style face="normal" font="default" size="100%">6</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>